|
Jul 30
|
Farxiga and Jardiance pose affordability issues, says Maryland drug board
|
|
Jul 30
|
Novo Nordisk A/S (NVO) Could Lose To Eli Lilly, Warns Jim Cramer
|
|
Jul 30
|
CVS Health Corporation (CVS) Is A Key Part Of Weight Loss Drug Distribution, Says Jim Cramer
|
|
Jul 30
|
Eli Lilly and Company (LLY): Jim Cramer’s “Bullish” On News Of Tariffs
|
|
Jul 30
|
Eli Lilly (LLY) Unveils Alzheimer's And CLL Trial Results With New LTZ Collaboration
|
|
Jul 30
|
NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead?
|
|
Jul 30
|
Novo Nordisk Stock Got Battered. Think Twice Before Buying the Dip.
|
|
Jul 30
|
Lilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease
|
|
Jul 30
|
MedaSystems Strengthens Executive Team with Appointment of Anton White as Vice President of Growth
|
|
Jul 30
|
Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL
|
|
Jul 29
|
Novo Nordisk shares plunge after profit warning over US weight-loss copycats
|
|
Jul 29
|
Why Eli Lilly Stock Was Looking Sickly Today
|
|
Jul 29
|
LipoVive Releases Ingredient Report Comparing Natural GLP-1 Support to Synthetic Drugs Like Mounjaro
|
|
Jul 29
|
Eli Lilly (LLY) Declines More Than Market: Some Information for Investors
|
|
Jul 29
|
Lilly set for strong quarter after Novo profit warning
|
|
Jul 29
|
Why Eli Lilly (LLY) Stock Is Falling Today
|
|
Jul 29
|
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
|
|
Jul 29
|
Eli Lilly (LLY) Announces Positive Results For Jaypirca In Phase 3 Trial
|
|
Jul 29
|
Novo Nordisk Shares Plummet as Competition Weighs on Sales
|
|
Jul 29
|
The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%.
|